

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein complex biogenesis (GO:0070271) | 4.90493877 |
| 2 | respiratory chain complex IV assembly (GO:0008535) | 4.88327525 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.84526867 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.79668114 |
| 5 | cytochrome complex assembly (GO:0017004) | 4.77977822 |
| 6 | DNA deamination (GO:0045006) | 4.61570997 |
| 7 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.52221808 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.38838886 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.38838886 |
| 10 | proteasome assembly (GO:0043248) | 4.38407527 |
| 11 | platelet dense granule organization (GO:0060155) | 4.28529876 |
| 12 | respiratory electron transport chain (GO:0022904) | 4.25654198 |
| 13 | electron transport chain (GO:0022900) | 4.24103138 |
| 14 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.91939526 |
| 15 | mannosylation (GO:0097502) | 3.90738553 |
| 16 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.89856126 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.89856126 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 3.89856126 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 3.88194503 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 3.69440697 |
| 21 | regulation of mitochondrial translation (GO:0070129) | 3.66894016 |
| 22 | protein-cofactor linkage (GO:0018065) | 3.66204389 |
| 23 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.48485124 |
| 24 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.48485124 |
| 25 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.41176183 |
| 26 | ketone body metabolic process (GO:1902224) | 3.30487065 |
| 27 | protein neddylation (GO:0045116) | 3.30244645 |
| 28 | maturation of 5.8S rRNA (GO:0000460) | 3.22133068 |
| 29 | ubiquinone biosynthetic process (GO:0006744) | 3.18211719 |
| 30 | cullin deneddylation (GO:0010388) | 3.16892150 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.14226987 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14226987 |
| 33 | termination of RNA polymerase III transcription (GO:0006386) | 3.12027974 |
| 34 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.12027974 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.07411186 |
| 36 | protein deneddylation (GO:0000338) | 3.06796987 |
| 37 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.06630333 |
| 38 | ubiquinone metabolic process (GO:0006743) | 2.99196399 |
| 39 | proton transport (GO:0015992) | 2.97449262 |
| 40 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.96424267 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.96344060 |
| 42 | hydrogen transport (GO:0006818) | 2.92858873 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.91978346 |
| 44 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84564386 |
| 45 | purine nucleotide salvage (GO:0032261) | 2.83960575 |
| 46 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.83842702 |
| 47 | regulation of hexokinase activity (GO:1903299) | 2.83548592 |
| 48 | regulation of glucokinase activity (GO:0033131) | 2.83548592 |
| 49 | metallo-sulfur cluster assembly (GO:0031163) | 2.82752542 |
| 50 | iron-sulfur cluster assembly (GO:0016226) | 2.82752542 |
| 51 | xenobiotic catabolic process (GO:0042178) | 2.80780656 |
| 52 | inositol phosphate catabolic process (GO:0071545) | 2.79869034 |
| 53 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.79712085 |
| 54 | inositol phosphate dephosphorylation (GO:0046855) | 2.79712085 |
| 55 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.78142974 |
| 56 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75880003 |
| 57 | cytidine metabolic process (GO:0046087) | 2.71238606 |
| 58 | cytidine catabolic process (GO:0006216) | 2.71238606 |
| 59 | cytidine deamination (GO:0009972) | 2.71238606 |
| 60 | piRNA metabolic process (GO:0034587) | 2.70557461 |
| 61 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.69876793 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.68691714 |
| 63 | ATP biosynthetic process (GO:0006754) | 2.68223571 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.67968170 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 2.67968170 |
| 66 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.66510527 |
| 67 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.66423126 |
| 68 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.66322524 |
| 69 | C-terminal protein lipidation (GO:0006501) | 2.66210679 |
| 70 | deoxyribonucleotide catabolic process (GO:0009264) | 2.65787222 |
| 71 | regulation of cilium movement (GO:0003352) | 2.65556291 |
| 72 | pseudouridine synthesis (GO:0001522) | 2.63944876 |
| 73 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.63285473 |
| 74 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.62914335 |
| 75 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61453494 |
| 76 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61453494 |
| 77 | glutathione derivative metabolic process (GO:1901685) | 2.60925556 |
| 78 | glutathione derivative biosynthetic process (GO:1901687) | 2.60925556 |
| 79 | quinone biosynthetic process (GO:1901663) | 2.60916877 |
| 80 | inner mitochondrial membrane organization (GO:0007007) | 2.60406075 |
| 81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.57869223 |
| 82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.57869223 |
| 83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.57869223 |
| 84 | adenosine metabolic process (GO:0046085) | 2.56673219 |
| 85 | rRNA modification (GO:0000154) | 2.56413984 |
| 86 | aldehyde catabolic process (GO:0046185) | 2.56282846 |
| 87 | branched-chain amino acid catabolic process (GO:0009083) | 2.55582686 |
| 88 | oxidative phosphorylation (GO:0006119) | 2.54618061 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 2.53224652 |
| 90 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.53184479 |
| 91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.53184479 |
| 92 | positive regulation of prostaglandin secretion (GO:0032308) | 2.51966558 |
| 93 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.50678410 |
| 94 | fucose catabolic process (GO:0019317) | 2.50594567 |
| 95 | L-fucose metabolic process (GO:0042354) | 2.50594567 |
| 96 | L-fucose catabolic process (GO:0042355) | 2.50594567 |
| 97 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50237968 |
| 98 | signal peptide processing (GO:0006465) | 2.49858635 |
| 99 | DNA double-strand break processing (GO:0000729) | 2.48909793 |
| 100 | fatty acid elongation (GO:0030497) | 2.47744844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.59349755 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.88800569 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38426359 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34615573 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.15928199 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.14095444 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00138112 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.91827397 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.56490226 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.55420834 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.54669264 |
| 12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39846730 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37599354 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17707943 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17331535 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.14305120 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13034138 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10566685 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02869153 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.01323149 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92579890 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87442531 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84831139 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77267320 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74308434 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71512114 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71064482 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69825124 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.69044687 |
| 30 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.62051411 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51929034 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51467050 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51440711 |
| 34 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49102144 |
| 35 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49102144 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48510913 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46473359 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45699334 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44456345 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41778342 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.41085206 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.41085206 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40741732 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39681040 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38642820 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38634559 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37271562 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37156485 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34210255 |
| 50 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32982739 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28633762 |
| 52 | AR_20517297_ChIP-Seq_VCAP_Human | 1.28228321 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27084159 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26194212 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23160040 |
| 56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20119394 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19568890 |
| 58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18196791 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15417669 |
| 60 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.14942610 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14884238 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 1.14438166 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13603127 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13541072 |
| 65 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.12527268 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12420736 |
| 67 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11935428 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11438784 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11438784 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10658584 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09294956 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08311829 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07150218 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05602965 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04599989 |
| 76 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04177459 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02325915 |
| 78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02210196 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01216639 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00452266 |
| 81 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99967188 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99960594 |
| 83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99515298 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98366425 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97293736 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96124935 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96100431 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96082053 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94590092 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94181206 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93903528 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93032831 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92787897 |
| 94 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90961524 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89468553 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88262058 |
| 97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.87260284 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86761223 |
| 99 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86629209 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86127086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.23433599 |
| 2 | MP0008877_abnormal_DNA_methylation | 2.73121762 |
| 3 | MP0003195_calcinosis | 2.72702269 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.70404265 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.49093344 |
| 6 | MP0003186_abnormal_redox_activity | 2.42101585 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.36647369 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 2.33435970 |
| 9 | MP0002163_abnormal_gland_morphology | 2.26163031 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.24348003 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.06784208 |
| 12 | MP0008058_abnormal_DNA_repair | 2.05689604 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.02719782 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.02352716 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.00108768 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.95472095 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 1.92014400 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 1.91339278 |
| 19 | MP0001764_abnormal_homeostasis | 1.87908348 |
| 20 | MP0009046_muscle_twitch | 1.82721959 |
| 21 | MP0005174_abnormal_tail_pigmentation | 1.71956613 |
| 22 | MP0003252_abnormal_bile_duct | 1.70472231 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.70469254 |
| 24 | MP0003011_delayed_dark_adaptation | 1.69755151 |
| 25 | MP0008872_abnormal_physiological_respon | 1.59544316 |
| 26 | MP0002736_abnormal_nociception_after | 1.58788028 |
| 27 | MP0001984_abnormal_olfaction | 1.57699453 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.57408666 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.57405488 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.57327816 |
| 31 | MP0003880_abnormal_central_pattern | 1.54390622 |
| 32 | MP0009697_abnormal_copulation | 1.54276850 |
| 33 | MP0006054_spinal_hemorrhage | 1.53270348 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.50141288 |
| 35 | MP0003718_maternal_effect | 1.49595566 |
| 36 | MP0001905_abnormal_dopamine_level | 1.49003562 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.48201610 |
| 38 | MP0005410_abnormal_fertilization | 1.45081481 |
| 39 | MP0002693_abnormal_pancreas_physiology | 1.43973126 |
| 40 | MP0005332_abnormal_amino_acid | 1.43667896 |
| 41 | MP0005253_abnormal_eye_physiology | 1.42124869 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.37124338 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.35326413 |
| 44 | MP0009785_altered_susceptibility_to | 1.34478952 |
| 45 | MP0003787_abnormal_imprinting | 1.33731466 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.32951774 |
| 47 | MP0004147_increased_porphyrin_level | 1.31568780 |
| 48 | MP0002102_abnormal_ear_morphology | 1.30173234 |
| 49 | MP0003786_premature_aging | 1.29478042 |
| 50 | MP0005671_abnormal_response_to | 1.26910080 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.24162019 |
| 52 | MP0002272_abnormal_nervous_system | 1.21867242 |
| 53 | MP0002160_abnormal_reproductive_system | 1.21444062 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.14757048 |
| 55 | MP0004142_abnormal_muscle_tone | 1.13768122 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.13739298 |
| 57 | MP0005389_reproductive_system_phenotype | 1.12815085 |
| 58 | MP0006082_CNS_inflammation | 1.12591274 |
| 59 | MP0005365_abnormal_bile_salt | 1.12233988 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.12116639 |
| 61 | MP0002938_white_spotting | 1.11743441 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.11668488 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.11337984 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 1.08690114 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.07327878 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.07292137 |
| 67 | MP0009745_abnormal_behavioral_response | 1.05453472 |
| 68 | MP0001944_abnormal_pancreas_morphology | 1.05376464 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.04662566 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.04176788 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.01306922 |
| 72 | MP0004885_abnormal_endolymph | 1.01214677 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.98866303 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.96641529 |
| 75 | MP0003646_muscle_fatigue | 0.96564493 |
| 76 | MP0001756_abnormal_urination | 0.93325102 |
| 77 | MP0002229_neurodegeneration | 0.92654906 |
| 78 | MP0002254_reproductive_system_inflammat | 0.92481978 |
| 79 | MP0001929_abnormal_gametogenesis | 0.92307211 |
| 80 | MP0005266_abnormal_metabolism | 0.92175312 |
| 81 | MP0005535_abnormal_body_temperature | 0.91706122 |
| 82 | MP0002090_abnormal_vision | 0.86452346 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.82174912 |
| 84 | MP0005360_urolithiasis | 0.81927386 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.80257622 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.78779542 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.78749164 |
| 88 | MP0001970_abnormal_pain_threshold | 0.77716666 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.77253261 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.75671538 |
| 91 | MP0002210_abnormal_sex_determination | 0.74747836 |
| 92 | MP0002735_abnormal_chemical_nociception | 0.74731050 |
| 93 | MP0008873_increased_physiological_sensi | 0.74617254 |
| 94 | MP0001529_abnormal_vocalization | 0.74360447 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.73633497 |
| 96 | MP0000516_abnormal_urinary_system | 0.73633497 |
| 97 | MP0000653_abnormal_sex_gland | 0.72396061 |
| 98 | MP0008469_abnormal_protein_level | 0.71547542 |
| 99 | MP0004133_heterotaxia | 0.69987632 |
| 100 | MP0009764_decreased_sensitivity_to | 0.69746387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.73600399 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.50202723 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.29984144 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.20261736 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.16280983 |
| 6 | Acute encephalopathy (HP:0006846) | 4.14973780 |
| 7 | Increased CSF lactate (HP:0002490) | 4.14177658 |
| 8 | Hepatic necrosis (HP:0002605) | 4.01425397 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.52889002 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.52445930 |
| 11 | Cerebral edema (HP:0002181) | 3.30406105 |
| 12 | Type I transferrin isoform profile (HP:0003642) | 3.29273110 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.14040767 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.13266792 |
| 15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00751544 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00751544 |
| 17 | Methylmalonic acidemia (HP:0002912) | 2.87831034 |
| 18 | Lactic acidosis (HP:0003128) | 2.83097386 |
| 19 | Pancreatic cysts (HP:0001737) | 2.80923896 |
| 20 | Respiratory failure (HP:0002878) | 2.80288841 |
| 21 | Increased serum lactate (HP:0002151) | 2.74516407 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.73037545 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.73037545 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.73037545 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.73037545 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 2.66121725 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.58480406 |
| 28 | Glycosuria (HP:0003076) | 2.57287472 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 2.57287472 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.56542195 |
| 31 | Optic disc pallor (HP:0000543) | 2.54019968 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 2.49354638 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 2.49354638 |
| 34 | Methylmalonic aciduria (HP:0012120) | 2.48256004 |
| 35 | Pancreatic fibrosis (HP:0100732) | 2.45817756 |
| 36 | Lethargy (HP:0001254) | 2.45210339 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.40315001 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.37225664 |
| 39 | CNS demyelination (HP:0007305) | 2.37092663 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 2.36356855 |
| 41 | Ketoacidosis (HP:0001993) | 2.36242921 |
| 42 | Increased muscle lipid content (HP:0009058) | 2.35713304 |
| 43 | Nephronophthisis (HP:0000090) | 2.34961116 |
| 44 | Renal cortical cysts (HP:0000803) | 2.30287378 |
| 45 | Exertional dyspnea (HP:0002875) | 2.29917783 |
| 46 | True hermaphroditism (HP:0010459) | 2.28037708 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.26293039 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26073804 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.26073804 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.25318156 |
| 51 | Ketosis (HP:0001946) | 2.25263845 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25061552 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.24149572 |
| 54 | Abnormality of renal resorption (HP:0011038) | 2.23581477 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.23445140 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21782306 |
| 57 | Hypoglycemic coma (HP:0001325) | 2.19667780 |
| 58 | Hypothermia (HP:0002045) | 2.15531606 |
| 59 | Exercise intolerance (HP:0003546) | 2.12738316 |
| 60 | Aplastic anemia (HP:0001915) | 2.11372054 |
| 61 | Abnormality of vitamin B metabolism (HP:0004340) | 2.10847283 |
| 62 | Stomatitis (HP:0010280) | 2.08189043 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.02428321 |
| 64 | Leukodystrophy (HP:0002415) | 2.01937518 |
| 65 | Hypoproteinemia (HP:0003075) | 2.01810781 |
| 66 | Opisthotonus (HP:0002179) | 2.01379332 |
| 67 | Constricted visual fields (HP:0001133) | 1.99845780 |
| 68 | Hypoglycemic seizures (HP:0002173) | 1.98542590 |
| 69 | Large for gestational age (HP:0001520) | 1.98310606 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 1.96301068 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94776762 |
| 72 | Polydipsia (HP:0001959) | 1.89018784 |
| 73 | Abnormal drinking behavior (HP:0030082) | 1.89018784 |
| 74 | Hyperglycinemia (HP:0002154) | 1.88497599 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86717496 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84538106 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 1.84538106 |
| 78 | Hyperalaninemia (HP:0003348) | 1.84538106 |
| 79 | Hypomagnesemia (HP:0002917) | 1.84016376 |
| 80 | Degeneration of anterior horn cells (HP:0002398) | 1.83401725 |
| 81 | Abnormality of the anterior horn cell (HP:0006802) | 1.83401725 |
| 82 | Oral leukoplakia (HP:0002745) | 1.80599888 |
| 83 | Hyperphosphaturia (HP:0003109) | 1.79663738 |
| 84 | Respiratory difficulties (HP:0002880) | 1.77801726 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76514638 |
| 86 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.72648885 |
| 87 | Bile duct proliferation (HP:0001408) | 1.71234145 |
| 88 | Abnormal biliary tract physiology (HP:0012439) | 1.71234145 |
| 89 | Progressive neurologic deterioration (HP:0002344) | 1.71141716 |
| 90 | Palpitations (HP:0001962) | 1.69696873 |
| 91 | Hyperglycemia (HP:0003074) | 1.69319750 |
| 92 | Emotional lability (HP:0000712) | 1.68339702 |
| 93 | Progressive microcephaly (HP:0000253) | 1.67933362 |
| 94 | Pancytopenia (HP:0001876) | 1.67397013 |
| 95 | Abnormality of the pons (HP:0007361) | 1.66027108 |
| 96 | Thyroiditis (HP:0100646) | 1.65744509 |
| 97 | Hypoplasia of the pons (HP:0012110) | 1.65738917 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63836454 |
| 99 | Hypoplasia of the fovea (HP:0007750) | 1.63671389 |
| 100 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.63671389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.62864034 |
| 2 | MAP4K2 | 3.33852148 |
| 3 | FRK | 3.23728314 |
| 4 | BCKDK | 2.92204939 |
| 5 | MST4 | 2.61450581 |
| 6 | ADRBK2 | 2.37885873 |
| 7 | ZAK | 2.28908666 |
| 8 | NUAK1 | 2.02703357 |
| 9 | TXK | 1.87469053 |
| 10 | MAP3K12 | 1.86024497 |
| 11 | WNK3 | 1.82942440 |
| 12 | BMPR1B | 1.81156637 |
| 13 | VRK1 | 1.75905451 |
| 14 | EIF2AK3 | 1.73362622 |
| 15 | GRK1 | 1.73161817 |
| 16 | ACVR1B | 1.72226817 |
| 17 | PASK | 1.66931733 |
| 18 | TRIM28 | 1.62893228 |
| 19 | KDR | 1.61249219 |
| 20 | STK16 | 1.60324552 |
| 21 | NME2 | 1.54999190 |
| 22 | INSRR | 1.48017985 |
| 23 | OXSR1 | 1.45759461 |
| 24 | TLK1 | 1.39595358 |
| 25 | BUB1 | 1.26814748 |
| 26 | WNK4 | 1.23261521 |
| 27 | PINK1 | 1.20431752 |
| 28 | PHKG2 | 1.20350747 |
| 29 | PHKG1 | 1.20350747 |
| 30 | CSNK1G3 | 1.19636575 |
| 31 | STK39 | 1.16983495 |
| 32 | MAP2K6 | 1.15726565 |
| 33 | CSNK1G1 | 1.14246966 |
| 34 | ARAF | 1.09605176 |
| 35 | CSNK1G2 | 1.03853400 |
| 36 | DAPK1 | 1.02361220 |
| 37 | EIF2AK1 | 1.00592998 |
| 38 | PIM2 | 1.00353486 |
| 39 | PRKCE | 0.98395757 |
| 40 | KIT | 0.97144658 |
| 41 | MUSK | 0.95539628 |
| 42 | PLK2 | 0.93683979 |
| 43 | TEC | 0.92202257 |
| 44 | PLK3 | 0.89249915 |
| 45 | DAPK2 | 0.88480736 |
| 46 | TAOK3 | 0.87181417 |
| 47 | TNIK | 0.85695194 |
| 48 | PLK4 | 0.84976362 |
| 49 | ADRBK1 | 0.84147644 |
| 50 | CDK19 | 0.82470361 |
| 51 | MYLK | 0.81722233 |
| 52 | DYRK2 | 0.81331126 |
| 53 | ITK | 0.79056483 |
| 54 | IKBKB | 0.78952032 |
| 55 | PAK3 | 0.78294629 |
| 56 | PDK2 | 0.77970399 |
| 57 | MAPK13 | 0.77421542 |
| 58 | ABL2 | 0.74303152 |
| 59 | BRSK2 | 0.72966959 |
| 60 | CSNK1A1L | 0.72909412 |
| 61 | SYK | 0.72830011 |
| 62 | PRKCQ | 0.70979358 |
| 63 | LIMK1 | 0.70338034 |
| 64 | NME1 | 0.69971597 |
| 65 | MAP3K4 | 0.69619341 |
| 66 | TAF1 | 0.68004398 |
| 67 | PRKCG | 0.67730974 |
| 68 | GRK5 | 0.67021851 |
| 69 | PBK | 0.60368136 |
| 70 | GRK7 | 0.57960950 |
| 71 | TNK2 | 0.56331577 |
| 72 | CAMKK2 | 0.53617148 |
| 73 | RPS6KA5 | 0.53160577 |
| 74 | MAPKAPK5 | 0.51530368 |
| 75 | CAMK2D | 0.50578328 |
| 76 | IKBKE | 0.48635180 |
| 77 | TRPM7 | 0.47769474 |
| 78 | NEK1 | 0.46975527 |
| 79 | PLK1 | 0.46958943 |
| 80 | OBSCN | 0.46366359 |
| 81 | MAP4K1 | 0.45352311 |
| 82 | CSNK1A1 | 0.44974772 |
| 83 | TESK1 | 0.44325118 |
| 84 | SCYL2 | 0.44091464 |
| 85 | CSNK2A1 | 0.44053192 |
| 86 | PRKCA | 0.43445235 |
| 87 | ERBB3 | 0.42683336 |
| 88 | TESK2 | 0.42666272 |
| 89 | PRKACA | 0.42539683 |
| 90 | PRKG1 | 0.41668255 |
| 91 | PRKCI | 0.40874920 |
| 92 | TIE1 | 0.38465067 |
| 93 | PTK2B | 0.38080524 |
| 94 | LYN | 0.37486886 |
| 95 | NLK | 0.37313811 |
| 96 | DAPK3 | 0.37084335 |
| 97 | EIF2AK2 | 0.36523929 |
| 98 | CSNK2A2 | 0.35817685 |
| 99 | CAMK2A | 0.35522272 |
| 100 | JAK3 | 0.35292224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.09010597 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.36793142 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.22552330 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.03676175 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.42106117 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.17108921 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16583471 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.12307208 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.10525623 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.06329326 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.05520173 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.99076368 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.84972367 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82991838 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.70293210 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64027875 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63041425 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56876474 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.55544870 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50577621 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48163616 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.48013700 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42733488 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36650946 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36424958 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.32521515 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27209769 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26826573 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.26010705 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.24814189 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22863235 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22777168 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.21606311 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20961126 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19518606 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13258580 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10332643 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10003333 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08606925 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.07270738 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06628877 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06382377 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04427879 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03870400 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01328246 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01267322 |
| 47 | DNA replication_Homo sapiens_hsa03030 | 1.00695701 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 0.99777674 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 0.97107043 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96425216 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95904125 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92015941 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90812266 |
| 54 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89359298 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85110728 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.85023715 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83236342 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83048683 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82367761 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79153442 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79130616 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78804510 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78385385 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77535693 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75862099 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73972113 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71721850 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70697607 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68735322 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67891672 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66688448 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66447183 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66235272 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65034367 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.62020969 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61817108 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60515895 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60278698 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59995286 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59789753 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56952665 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56892810 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55827169 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51250103 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51242534 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49734612 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48628824 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47116477 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.46450537 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45154062 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39174971 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38430121 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.36994393 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36451288 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35819328 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.34389781 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33210100 |
| 98 | Spliceosome_Homo sapiens_hsa03040 | 0.32198507 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31625135 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30318243 |

